Pharmacodynamics of fluconazole, itraconazole, and amphotericin B against Candida albicans

Diagnostic Microbiology and Infectious Disease

Volumn 36, Issue 1, 2000, Pages 13-18

  Burgess, David S ^a,b   Hastings, Rhonda W ^a,b   Summers, Kimberly K ^a,b,c   Hardin, Thomas C ^a,b,c   Rinaldi, Michael G ^b,c  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ITRACONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG POTENCY; DRUG RESISTANCE; FUNGUS GROWTH; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; COLONY COUNT, MICROBIAL; FLUCONAZOLE; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; SENSITIVITY AND SPECIFICITY;

EID: 0033955621     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(99)00097-8     Document Type: Article

References (13)

1. National Nosocomial Infections Surveillance System , Banerjee S.N., Emori T.G., Culver D.H., Gaynes R.P., Jarvis W.R., Horan T., Edwards J.R., Tolson J., Henderson T., Martone W.J. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am J Med. 91:(Suppl B):1991;86S-89S.
2. National Nosocomial Infections Surveillance System , Beck-Sague C.M., Jarvis W.R. Secular trends in the epidemology of nosocomial fungal infections in the United States, 1980-1990. J Infect Dis. 167:1993;1247-1251.
3. Bryce E.A., Roberts F.J., Sekhon A.S., Coldman A.J. Yeast in blood cultures Evaluation of factors influencing outcomes . Diagn Microbiol Infect Dis. 15:1992;233-237.
4. Fox J.L. Fungal Infection Rates are Increasing. ASM News. 59:1993;515-518.
5. Fraser V.J., Jones M., Dunkel J., Storfer S., Medoff G., Dunagan W.C. Candidemia in a tertiary care hospital epidemology, risk factors, and predictors of motality . Clin Inf Dis. 15:1992;414-421.
6. Guiot H.F.L., Fibbe W.E., van't Wout J.W. Risk factors for fungal infection in patients with malignant hematologic disorders Implications for empirical therapy and prophylaxis . Clin Inf Dis. 18:1994;525-532.
7. Klepser M.E., Wolfe E.J., Jones R.N., Nightingale C.H., Pfaller M.A. Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans. Antimicrob Agents Chemother. 41:1997;1392-1395.
8. Meunier F., Lambert C., Van der Auwera P. In-vitro activity of SCH 39304 in comparison with amphotericin B and fluconazole. J Antimicrob Chemother. 25:1990;227-236.
9. National Committee for Clinical Laboratory Standards. (1997). Reference method for broth dilution antifungal susceptibility testing for yeasts. Approved standards M27-T. Villanova, PA: National Committee for Clinical Laboratory Standards.
10. Rex J.H., Bennett J.E., Sugar A.M., Pappas P.G., van der Horst C.M., Edwards J., Washburn R.G., Scheld W.M., Karchmer A.W., Dine A.P., Levenstein M.J., Webb C.D., for the Candidemia Study Group and the National Institute of Allergy and Infectious Disease Mycoses Study Group. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med. 331:1994;1325-1330.
11. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards , Rex J.H., Pfaller M.A., Galigiani J.N., Bartlett M.S., Espinel-Ingroff A., Ghannoum M.A., Lancaster M., Odds F.C., Rinaldi M.G., Walsh T.J., Barry A.L. Development of interpretive breakpoints for antifungal susceptibility testing Conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections . Clin Infect Dis. 24:1997;235-247.
12. Rex J.H., Cooper C.R., Merz W.H., Galgiani J.N., Anaissie E.J. Detection of amphotericin B-resistant candida isolates in a broth-based system. Antimicrob Agents Chemother. 39:1995;906-909.
13. Yorassowsky E., Van der Linden M.P., Crokaert F., Glupczynski Y. Effect of antibiotic carry-over on bacterial counting by "spiral plating." J Antimicrob Chemother. 21:1988;138-140.